Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 19, 2025 • 8:01 PM ET

Date/Time Source News Release
11/22/2024 09:00 AM EST TheNewsWire Ocumetics Provides Update on Accommodative Intraocular Lens Internal Tests
08/29/2024 09:00 AM EDT TheNewsWire Ocumetics Announces Successful Manufacture of Accommodating Intraocular Lens Designed to Respond to Muscle Activity That Changes the Focus of the Human Eye
08/08/2024 09:00 AM EDT TheNewsWire Ocumetics Announces Completion of New Injector Delivery System for the Ocumetics Accommodative Intraocular Lens
07/22/2024 09:10 AM EDT TheNewsWire Ocumetics Begins to Manufacture Accommodating Intraocular Lenses for First-In-Human Study
06/24/2024 08:45 AM EDT TheNewsWire Ocumetics Announces Completion of Second Tranche of Debenture Private Placement for Net Proceeds of CA $940,000
06/21/2024 04:15 PM EDT TheNewsWire Ocumetics Announces Completion of Second Tranche of Debenture Private Placement for Net Proceeds of CA$940,000
05/24/2024 09:10 AM EDT TheNewsWire Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million
05/15/2024 08:55 PM EDT TheNewsWire Ocumetics Announces Offering of up to $4 million of Secured Convertible Debentures
02/29/2024 08:10 AM EST TheNewsWire Ocumetics Technology Corp (OTC) To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar (Feb 29, 2024)
01/17/2024 09:00 AM EST TheNewsWire Ocumetics Announces Completion of Unit Private Placement
Page

Additional News

As of August 19, 2025 • 8:01 PM ET

Date/Time Source News Release
There are no press releases available at this time.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.